ArticleArthritis & rheumatology (Hoboken, N.J.)2019

Efficacy of Baricitinib in the Treatment of Chilblains Associated With Aicardi-Goutières Syndrome, a Type I Interferonopathy.

Kornvalee Meesilpavikkai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.